Pompe Disease - Market Insight, Epidemiology and Market Forecast - 2027

Pompe Disease - Market Insight, Epidemiology and Market Forecast - 2027

  • Pages: 120
  • Geography: Global
  • Delivery Timeline: 5 Business Days
  • Publication: Aug, 2018
  • SKU: DIMI0172
  • Single User License
    (20% Off)
    $6,250.00
    $5000
  • Site License
    (30% Off)
    $12,500.00
    $8750
  • Global License
    (40% Off)
    $18,750.00
    $11250
Request Sample

Name*  
Email ID*  
Mobile*  
Company*  
Country*  
Zip Code*  
Address*  
Message*  
X

Request Sample Pages

Request Before Buy
Name*  
Email ID*  
Mobile*  
Company*  
Message*  
X

Inquire Before Buy

Send Friend
Name*  
Email ID*  
Mobile*  
Company*  
Message*  
X

Send to Friend

DelveInsight’s ‘Pompe Disease  - Market Insights, Epidemiology and Market Forecast-2027’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of Pompe Disease in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.
The Report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of Pompe Disease from 2016 to 2027 segmented by seven major markets. The Report also covers current treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assess underlying potential of the market.

Geography Covered

• The United States

• EU5 (Germany, France, Italy, Spain and the United Kingdom)

• Japan

Study Period: 2016-2027
Pompe Disease - Disease Understanding and Treatment Algorithm
Pompe disease (also known as glycogen storage disease type II [GSDII], acid maltase deficiency or GAA deficiency) is an autosomal recessive inherited disorder caused by a mutation in the gene encoding GAA. Deficiency in GAA affects lysosomal-mediated degradation of glycogenesis and results in intralysosomal accumulation of glycogen and disruption of the tissue architecture in various organs, most notably the skeletal muscles, heart and liver.
The DelveInsight Pompe Disease market report gives the thorough understanding of the Pompe Disease by including details such as disease definition, classification, symptoms, etiology, pathophysiology, diagnostic trends. It also provides treatment algorithms and treatment guidelines for Pompe Disease in the US, Europe, and Japan.

Pompe Disease Epidemiology
The Pompe Disease epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken. 
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology scenario of Pompe Disease in the 7MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2016-2027.
According to Clinical Therapeutics- Genetics and epidemiology of Pompe disease, the overall worldwide incidence of Pompe Disease is usually estimated to be 1:40,000 live births with the late-onset form of the disease generally being more common than the early neonatal form. According to US National Library of Medicine National Institutes of Health, the prevalence of Pompe disease is approximately 1 in 28,000 in the United States.
 
Pompe Disease Drug Chapters
This segment of the Pompe Disease report encloses the detailed analysis of marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. It also helps to understand the clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.
The treatment of Pompe disease is disease-specific, symptomatic, and supportive. Enzyme replacement therapy is an approved treatment for all patients with Pompe disease. Myozyme (alglucosidase alfa), the first and only enzyme replacement therapy (ERT) to treat the underlying cause of Pompe disease, has been approved for use in several countries around the world. Apart from ERT, alternative treatments for Pompe disease, such as gene therapy and substrate reduction therapy can also be considered as an attractive option in future.

Pompe Disease Market Outlook
The Pompe Disease market outlook of the report helps to build the detailed comprehension of the historic, current and forecasted trend of the market by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology. 
This segment gives a through detail of market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria’s, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight. 
Key players such as Sanofi, Amicus Therapeutics, Valerion Therapeutics and many others are involved in developing therapies for Pompe Disease. Expected launch of emerging therapies such as GZ402666 (Sanofi), AT-2220 (Amicus Therapeutics), and other compelling treatments, are expected to impact the market size of Pompe Disease in upcoming years.

Pompe Disease Drugs Uptake
This section focusses on the rate of uptake of the potential drugs recently launched in the market or will get launched in the market during the study period from 2016-2027. The analysis covers market uptake by drugs; patient uptake by therapies and sales of each drug.
This helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allows the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Pompe Disease Report Insights

• Patient Population

• Therapeutic Approaches

• Pipeline Analysis

• Market Size and Trends

• Market Opportunities

• Impact of upcoming Therapies

Pompe Disease Report Key Strengths

• 10 Years Forecast

• 7MM Coverage 

• Epidemiology Segmentation

• Sub-type Segmentation

• Key Cross Competition 

• Highly Analyzed Market

• Drugs Uptake

Pompe Disease Report Assessment

• Current Treatment Practices

• Unmet Needs

• Pipeline Product Profiles

• Market Attractiveness

• Market Drivers and Barriers

Key Benefits

• This DelveInsight report will help to develop Business Strategies by understanding the trends shaping and driving Pompe Disease market

• Organize sales and marketing efforts by identifying the best opportunities for Pompe Disease market

• To understand the future market competition in the Pompe Disease market.

1. Report Introduction
2. Pompe Disease  Market Overview at a Glance
2.1. 7 Major Market Size (%) of Pompe Disease  in 2017
2.2. 7 Major Market Size (%) of Pompe Disease  in 2027
3. Disease Background and Overview: Pompe Disease     
3.1. Introduction
3.2. Causes
3.3. Pathophysiology
3.4. Symptoms
3.5. Prognosis of infantile-onset Pompe disease (IOPD)
3.6. Prognosis of late-onset Pompe disease (LOPD)
4. Diagnostic approaches for identification of Pompe Disease
4.1 Biomarkers
5. Epidemiology and Patient Population
5.1. 7MM Prevalent Cases of Pompe Diseas (2016-2027)
5.2. 7MM Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)(2016-2027)
6. Pompe Disease   : Country- Wise Epidemiology
6.1. United States
6.1.1. Prevalent Cases of Pompe Disease    (2016-2027)
6.1.2. Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) (2016-2027)
6.2. EU-5
6.2.1. Assumptions and Rationale
6.2.2. Germany
6.2.2.1. Prevalent Cases of Pompe Disease (2016-2027)
6.2.2.2. Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)(2016-2027)
6.2.3. France
6.2.3.1. Prevalent Cases of Pompe Disease (2016-2027)
6.2.3.2. Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)(2016-2027)
6.2.4. Italy
6.2.4.1. Prevalent Cases of Pompe Disease (2016-2027)
6.2.4.2. Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)(2016-2027)
6.2.5. Spain
6.2.5.1. Prevalent Cases of Pompe Disease (2016-2027)
6.2.5.2. Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)(2016-2027)
6.2.6. United Kingdom
6.2.6.1. Prevalent Cases of Pompe Disease    (2016-2027)
6.2.6.2. Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)(2016-2027)
6.3. Japan
6.3.1. Prevalent Cases of Pompe Disease (2016-2027)
6.3.2. Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)(2016-2027)
7. Treatments & Medical Practices
7.1. Treatment Algorithm
7.2. Treatment Guidelines
8. Marketed Products
8.1. Myozyme/ Lumizyme: Genzyme
8.1.1. Drug Description
8.1.2. Mechanism of Action
8.1.3. Regulatory Milestones
8.1.4. Advantages and Disadvantages
8.1.5. Safety and Efficacy
8.1.6. Product Profile
9. Emerging Therapies
9.1. Key Cross Competition
9.2. GZ402666: Sanofi 
9.2.1. Regulatory Milestones
9.2.2. Clinical Development
9.2.3. Product Profile
9.2.4. Clinical Pipeline Activity
9.2.4.1. Ongoing Trials Information
9.2.4.2. Clinical Trial by Phase
9.3. AT-2220: Amicus Therapeutics
9.3.1.  Regulatory Milestones
9.3.2.  Clinical Development
9.3.3.  Product Profile
9.3.4.  Clinical Pipeline Activity
9.3.4.1. Ongoing Trials Information
9.3.4.2. Clinical Trial by Phase
9.4. VAL-1221: Valerion Therapeutics
9.4.1.  Regulatory Milestones
9.4.2.  Clinical Development
9.4.3.  Product Profile
9.4.4.  Clinical Pipeline Activity
9.4.4.1. Ongoing Trials Information
9.4.4.2. Clinical Trial by Phase
To be continued in report…
10. Pompe Disease Market Size
10.1. Key Findings
10.2. Total 7MM Pompe Disease Market Analysis 
10.2.1. Overview of Total Pompe Disease  Market 
10.2.2.  Market size of Pompe Disease Market by 7MM (2016-2027)
11. 7MM: Country-Wise Market Analysis
11.1. United States Market Size
11.1.1. Total Market Size of Pompe Disease    
11.1.2. Market Size of Pompe Disease by Therapies
11.2. Germany Market Size
11.2.1. Total Market Size of Pompe Disease    
11.2.2. Market Size of Pompe Disease by Therapies
11.3. France Market Size
11.3.1. Total Market Size of Pompe Disease    
11.3.2. Market Size of Pompe Disease by Therapies
11.4. United Kingdom Market Size
11.4.1. Total Market Size of Pompe Disease    
11.4.2. Market Size of Pompe Disease by Therapies
11.5. Spain Market Size
11.5.1. Total Market Size of Pompe Disease    
11.5.2. Market Size of Pompe Disease by Therapies
11.6. Italy Market Size
11.6.1. Total Market Size of Pompe Disease    
11.6.2. Market Size of Pompe Disease by Therapies
11.7. Japan Market Size
11.7.1. Total Market Size of Pompe Disease    
11.7.2. Market Size of Pompe Disease by Therapies
12. Market Drivers
13. Market Barriers
14. Report Methodology
14.1. Sources Used
15. DelveInsight Capabilities
16. Disclaimer
17. About DelveInsight

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Table 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Table 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Table 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Table 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Table 5 Prevalent Cases of Pompe Disease in the Germany (2016-2027)
Table 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Table 7 Prevalent Cases of Pompe Disease in the Italy (2016-2027)
Table 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)  in Italy (2016-2027)
Table 9 Prevalent Cases of Pompe Disease in Spain (2016-2027)
Table 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Spain (2016-2027)
Table 11 Prevalent Cases of Pompe Disease in France (2016-2027)
Table 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in France (2016-2027)
Table 13 Prevalent Cases of Pompe Disease  in the UK (2016-2027)
Table 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the UK (2016-2027)
Table 15 Prevalent Cases of Pompe Disease in the Japan (2016-2027)
Table 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Japan (2016-2027)
Table 17 GZ402666, Clinical Trials by Recruitment status, 2018
Table 18 GZ402666, Clinical Trials by Zone, 2018
Table 19 AT-2220, Clinical Trials by Recruitment status, 2018
Table 20 AT-2220, Clinical Trials by Recruitment status, 2018
Table 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Table 22 VAL-1221, Clinical Trials by Zone, 2018
Table 23 7MM-Market Size by Therapy in USD, Million (2016-2027)
Table 24 United States Market Size in USD, Million (2016-2027)
Table 25 United States Market Size by Therapy in USD, Million (2016-2027)
Table 26 Germany  Market Size in USD, Million (2016-2027)
Table 27 Germany Market Size by Therapy in USD, Million (2016-2027)
Table 28 France  Market Size in USD, Million (2016-2027)
Table 29 France Market Size by Therapy in USD, Million (2016-2027)
Table 30 United Kingdom  Market Size in USD, Million (2016-2027)
Table 31 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Table 32 Spain Market Size in USD, Million (2016-2027)
Table 33 Spain Market Size by Therapy in USD, Million (2016-2027)
Table 34 Italy Market Size in USD, Million (2016-2027)
Table 35 Italy Market Size by Therapy in USD, Million (2016-2027)
Table 36 Japan Market Size in USD, Million (2016-2027)
Table 37 Japan Market Size by Therapy in USD, Million (2016-2027)

 

Figure 1 Prevalent Cases of Pompe Disease in 7MM (2016-2027)
Figure 2 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in 7MM (2016-2027)
Figure 3 Prevalent Cases of Pompe Disease in the US (2016-2027)
Figure 4 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in the US (2016-2027)
Figure 5 Prevalent Cases of Pompe Disease   in the Germany (2016-2027)
Figure 6 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD) in Germany (2016-2027)
Figure 7 Prevalent Cases of Pompe Disease in  Italy (2016-2027)
Figure 8 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)in Italy (2016-2027)
Figure 9 Prevalent Cases of Pompe Disease   in Spain (2016-2027)
Figure 10 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Spain (2016-2027)
Figure 11 Prevalent Cases of Pompe Disease   in France (2016-2027)
Figure 12 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in France (2016-2027)
Figure 13 Prevalent Cases of Pompe Disease    in the UK (2016-2027)
Figure 14 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in the UK (2016-2027)
Figure 15 Prevalent Cases of Pompe Disease   in the Japan (2016-2027)
Figure 16 Prevalent Cases of Pompe Disease by Age of onset (IOPD & LOPD)   in Japan (2016-2027)
Figure 17 GZ402666, Clinical Trials by Recruitment status, 2018
Figure 18 GZ402666, Clinical Trials by Zone, 2018
Figure 19 AT-2220, Clinical Trials by Recruitment status, 2018
Figure 20 AT-2220, Clinical Trials by Zone, 2018
Figure 21 VAL-1221, Clinical Trials by Recruitment status, 2018
Figure 22 VAL-1221, Clinical Trials by Zone, 2018
Figure 23 Region wise Market Size) in USD, Million (2016-2027)
Figure 24 7MM-Market Size by Therapy in USD, Million (2016-2027)
Figure 25 United States Market Size in USD, Million (2016-2027)
Figure 26 United States Market Size by Therapy in USD, Million (2016-2027)
Figure 27 Germany  Market Size in USD, Million (2016-2027)
Figure 28 Germany Market Size by Therapy in USD, Million (2016-2027)
Figure 29 France  Market Size in USD, Million (2016-2027)
Figure 30 France Market Size by Therapy in USD, Million (2016-2027)
Figure 31 United Kingdom  Market Size in USD, Million (2016-2027)
Figure 32 United Kingdom Market Size by Therapy in USD, Million (2016-2027)
Figure 33 Spain Market Size in USD, Million (2016-2027)
Figure 34 Spain Market Size by Therapy in USD, Million (2016-2027)
Figure 35 Italy Market Size in USD, Million (2016-2027)
Figure 36 Italy Market Size by Therapy in USD, Million (2016-2027)
Figure 37 Japan Market Size in USD, Million (2016-2027)
Figure 38 Japan Market Size by Therapy in USD, Million (2016-2027)
Figure 39 Market Drivers
Figure 40 Market Barriers

 

Key Companies
Speak to Analyst
Name*  
Email ID*  
Mobile*  
Company*  
Country*  
Zip Code*  
Specific Filed of Interest*  
X

Speak to Analyst

+1(919)321-6187

Related Reports

Contact Us

Phone

India: +91-11-45689769, +91-9650213330

Email

info@delveinsight.com

Address

New Delhi-110075, India

Address

304 S. Jones Blvd #2432, Las Vegas NV 89107

Phone

Outside India: +1(919)321-6187

Latest Tweets

Copyright © 2018 Delveinsight.